Has Wayne Woo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $30,117 in general payments to Wayne Woo, MD across 1,402 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wayne Woo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wayne Woo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wayne Woo, MD

Endocrinology, Diabetes & Metabolism · Flowood, MSNPI 1023064177

Payments from drug & device makers

$30,117in general payments, 2019–2025

Across 1,402 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Novo Nordisk$4K
Tandem Diabetes Care, Inc.$3K
Amgen$2K
Lilly USA, LLC$2K
AstraZeneca$2K
plus $13K from 46 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	157	$4,191
Novo Nordisk	142	$3,678
Tandem Diabetes Care, Inc.	18	$2,701
Amgen	101	$2,315
Lilly USA, LLC	163	$2,182
AstraZeneca(2 entities)	99	$1,922
Boehringer Ingelheim	96	$1,326
Bayer	56	$1,173
Sanofi-aventis U.S. LLC	62	$1,119
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	63	$990
AbbVie	62	$932
Merck	53	$919
Amarin Pharma, Inc.	29	$680
Novartis	42	$632
Radius Health, Inc.	31	$612
Dexcom, Inc.	37	$605
Corcept Therapeutics	21	$564
BETA Bionics, Inc.	17	$525
IBSA Pharma Inc.	20	$288
Amneal Pharmaceuticals LLC	13	$202
Arbor Pharmaceuticals, Inc.	13	$198
Tolmar, Inc.	11	$194
Esperion Therapeutics, Inc.	12	$182
Valeritas, Inc.	10	$169
Recordati_rare_diseases_inc.	7	$151
Madrigal Pharmaceuticals	5	$144
Nestle Healthcare Nutrition Inc.	2	$143
Regeneron Healthcare Solutions, Inc.	9	$141
GSK	3	$136
Xeris Pharmaceuticals, Inc.	6	$121
Roche Diabetes Care, Inc.	2	$112
Shire North American Group Inc	2	$102
Neurocrine Biosciences, Inc.	4	$89
Bard Peripheral Vascular, Inc.	1	$68
Embecta Corp.	3	$59
Medtronic(2 entities)	3	$59
Lifescan, Inc.	4	$57
EUSA Pharma (US) LLC	3	$55
Ascendis Pharma Endocrinology Inc	3	$53
Acerus Pharmaceuticals Corporation	3	$50
Cequr Corporation	1	$47
Halozyme Inc	2	$33
Amryt Pharma Holdings Ltd	2	$31
Insulet Corporation	1	$30
Antares Pharma, Inc.	1	$23
Sequel Med Tech, LLC	1	$22
Pfizer	1	$20
Vifor Pharma, Inc.	1	$16
Ascensia Diabetes Care US Inc.	1	$15
GRT US Holding, Inc.	1	$14
BD	1	$13
Kowa Pharmaceuticals America, Inc.	1	$13

How this compares

$30,117 in reported general payments places this provider in the 75th percentile of 48 endocrinology, diabetes & metabolism providers in Mississippi.

See all endocrinology, diabetes & metabolism providers in Mississippi →

Medicare billing

Part B allowed, 2024

$314,453

Medicare patients

546

Services billed

38,185

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Flowood

Mark BorcheltGulfport$1.1M
Honey EastJackson$904K
Eric DyessJackson$885K
Ben SealeJackson$623K
Jeremy TaylorMadison$271K
Amanda SchieferJackson$204K
Delali BlavoSouthaven$148K
John SistrunkJackson$133K
Richard GallowayHattiesburg$109K
James PowellHattiesburg$88K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →